Skip to main content
. 2016 Mar 1;11(3):e0149684. doi: 10.1371/journal.pone.0149684

Fig 26. Inhibition introduced in the ERK-Gab1-PI3K pathway (e.g. increasing k3) alleviates the activation of ERK due to mTOR inhibition (after ramapycin treatment).

Fig 26